Federal Register/Vol. 85, No. 100/Friday, May 22, 2020/Notices

Federal Register / Vol. 85, No. 100 / Friday, May 22, 2020 / Notices 31227

[email protected], Email: Active Pharmaceutical Ingredient (API) evidence or arguments they wish to [email protected]. for supply to its customers. In reference present, the names and addresses of Attorneys for Plaintiff United States to drug codes 7360 (Marihuana) and proposed participants, and an [FR Doc. 2020–11073 Filed 5–21–20; 8:45 am] 7370 (Tetrahydrocannabinols), the indication of the approximate time BILLING CODE 4410–11–P company plans to bulk manufacture requested to make their presentation on these drugs as synthetics. No other or before June 8, 2020. activities for these drug codes are General Information: NIC welcomes DEPARTMENT OF JUSTICE authorized for this registration. This the attendance of the public at its notice does not constitute an evaluation advisory committee meetings and will Drug Enforcement Administration or determination of the merits of the make every effort to accommodate [Docket No. DEA–645] company’s application. persons with physical disabilities or special needs. If you require special William T. McDermott, Bulk Manufacturer of Controlled accommodations due to a disability, Substances Application: Noramco, Inc. Assistant Administrator. please contact Susan Walters at least 7 [FR Doc. 2020–11077 Filed 5–21–20; 8:45 am] days in advance of the meeting. Notice ACTION: Notice of application. BILLING CODE 4410–09–P of this meeting is given under the Federal Advisory Committee Act (5 DATES: Registered bulk manufacturers of U.S.C. app. 2). the affected basic class(es), and DEPARTMENT OF JUSTICE applicants therefore, may file written Shaina Vanek, comments on or objections to the National Institute of Corrections Acting Director, National Institute of Corrections. issuance of the proposed registration on Advisory Board; Notice of Meeting or before July 21, 2020. [FR Doc. 2020–11051 Filed 5–21–20; 8:45 am] ADDRESSES: Written comments should This notice announces a forthcoming BILLING CODE 4410–36–P be sent to: Drug Enforcement virtual meeting of the National Institute Administration, Attention: DEA Federal of Corrections (NIC) Advisory Board. Register Representative/DPW, 8701 The meeting will be open to the public. DEPARTMENT OF LABOR Morrissette Drive, Springfield, Virginia Name of the Committee: NIC Office of the Secretary 22152. Advisory Board. General Function of the Committee: SUPPLEMENTARY INFORMATION: In To aid the National Institute of Agency Information Collection accordance with 21 CFR 1301.33(a), this Corrections in developing long-range Activities; Submission for OMB is notice that on February 26, 2020, plans, advise on program development, Review; Comment Request; Notice to Noramco, Inc., 500 Swedes Landing and recommend guidance to assist NIC’s Employees of Coverage Options Under Road, Wilmington, Delaware 19801– efforts in the areas of training, technical Fair Labor Standards Act Section 18B 4417, applied to be registered as a bulk assistance, information services, and ACTION: manufacturer of the following basic policy/program development assistance Notice of availability; request class(es) of controlled substances: to Federal, state, and local corrections for comments. agencies. SUMMARY: The Department of Labor Drug Date and Time: 11:00 a.m.–1:30 p.m. Controlled substance code Schedule (DOL) is submitting this Employee on Friday, June 19, 2020 (approximate). Benefits Security Administration Marihuana ...... 7360 I Location: Virtual Platform. (EBSA)-sponsored information Contact Person: Susan Walters, Tetrahydrocannabinols .. 7370 I collection request (ICR) to the Office of Executive Assistant, National Institute Codeine-N-oxide ...... 9053 I Management and Budget (OMB) for of Corrections, 320 First Street NW, Dihydromorphine ...... 9145 I review and approval in accordance with Hydromorphinol ...... 9301 I Room 901–3, Washington, DC 20534. To the Paperwork Reduction Act of 1995 Morphine-N-oxide ...... 9307 I contact Ms. Walters, please call (202) (PRA). Public comments on the ICR are Amphetamine ...... 1100 II 353–4213. Lisdexamfetamine ...... 1205 II Agenda: On Friday, June 19, 2020, the invited. Methylphenidate ...... 1724 II Advisory Board will receive a brief DATES: The OMB will consider all Nabilone ...... 7379 II Agency Report from the NIC Acting written comments that agency receives Phenylacetone ...... 8501 II on or before June 22, 2020. Codeine ...... 9050 II Director, with time for questions and Dihydrocodeine ...... 9120 II planning for subsequent FY20–FY21 ADDRESSES: Written comments and Oxycodone ...... 9143 II Advisory Board meeting(s). recommendations for the proposed Hydromorphone ...... 9150 II Procedure: On June 19, 2020, the information collection should be sent Hydrocodone ...... 9193 II meeting is open to the public. Interested within 30 days of publication of this Morphine ...... 9300 II persons may present data, information, notice to www.reginfo.gov/public/do/ Oripavine ...... 9330 II or views, orally or in writing, on issues PRAMain. Find this particular Thebaine ...... 9333 II pending before the committee. Written information collection by selecting Opium extracts ...... 9610 II submissions may be made to the contact ‘‘Currently under 30-day Review—Open Opium fluid extract ...... 9620 II person on or before June 8, 2020. Oral for Public Comments’’ or by using the Opium tincture ...... 9630 II Opium, powdered ...... 9639 II presentations from the public will be search function. Opium, granulated ...... 9640 II scheduled between approximately 1:00 Comments are invited on: (1) Whether Oxymorphone ...... 9652 II p.m. to 1:15 p.m. on June 19, 2020. Time the collection of information is Noroxymorphone ...... 9668 II allotted for each presentation may be necessary for the proper performance of Tapentadol ...... 9780 II limited. Those desiring to make formal the functions of the Department, oral presentations should notify the including whether the information will The company plans to manufacture contact person and submit a brief have practical utility; (2) if the the listed controlled substances as an statement of the general nature of the information will be processed and used

VerDate Sep<11>2014 18:07 May 21, 2020 Jkt 250001 PO 00000 Frm 00093 Fmt 4703 Sfmt 4703 E:\FR\FM\22MYN1.SGM 22MYN1